USPTO 2015–2025 USPTO PatentsView US Corporation

Glycosyn LLC

USPTO PatentsView assignee record - 20 granted patents across 14 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Glycosyn ranks #14,647 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 14 technology areas.

#14,647
of 49,997 US assignees by volume
Top 26%
by Innovation Score (44.4/100)
23.3
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14647 · US Corporation #14,647 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 20 grants
  • MID-PACK #14,647/49,997
  • PHOTO-FINISH Genomic Health
  • CPC-FOCUS C12P · 14 areas
  • INNOV-PAR 44.4/100
  • CLAIMS-DENSE 23.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Genomic Health, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glycosyn’s 44.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Glycosyn

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Glycosyn's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Glycosyn?

Each dot is one of Glycosyn’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glycosyn’s own 23.3 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Glycosyn vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 19.919.92020.1 10152025 Granted patents (volume) Avg claims / patent Genomic Health, Inc. - 20, 15.7Genomic HealthGenpact Luxembourg S.à r.l. II - 20, 22.15Genpact Luxembour…Geobrugg AG - 20, 15.9GeobruggGiesecke+Devrient Mobile Security America, Inc. - 20, 17.15Giesecke+Devrient…Greif International Holding B.V. - 20, 13.4Greif Internation…Haas Food Equipment GMBH - 20, 18.55Haas Food Equipme…Hanon Systems EFP Deutschland GMBH - 20, 11.35Hanon Systems EFP…Hempel A/S - 20, 16.85Hempel A/SGlycosyn LLC - 20, 23.3Glycosyn
Glycosyn vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glycosyn's grants concentrate

Glycosyn LLC is a focused PatentsView assignee: 14 CPC subclasses with 80% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2015. By volume, Glycosyn sits between Genomic Health, Inc. and Hempel A/S.

Glycosyn's three-year grant acceleration

Glycosyn LLC shows 7 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Glycosyn's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Glycosyn holds 20 patents at rank #14,650, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Glycosyn

By rank, the assignees closest to #14,650 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Glycosyn's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Glycosyn, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Glycosyn ranks #120 of 1,268 assignees by patent count in that subclass.

Glycosyn's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201520162017201820192020202120222023 2
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Glycosyn LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 5.0%
2016 1 5.0%
2017 3 15.0%
2018 1 5.0%
2019 4 20.0%
2020 1 5.0%
2021 2 10.0%
2022 5 25.0%
2023 2 10.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Glycosyn LLC's patent record in context - here's where to go next.

  • Glycosyn LLC's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 80% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #14,647 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Glycosyn LLC against Genomic Health, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.